About Multiplexed Diagnostics
Multiplexed diagnostics refer to equipment that are used for analyzing multiple analytes in the single cycle of the assay procedure. Multiplexed diagnostics can diagnose and run multiple tests on a specimen. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure. Multiplexed diagnostics find their use in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are used in various fields such as drugs-abuse screening, pharmacogenetics, and infection testing.
TechNavio's analysts forecast the Global Multiplexed Diagnostics market to grow at a CAGR of 20.05 percent over the period 2013-2018.
Covered in this Report
The Global Multiplexed Diagnostics market can be segmented into revenue generated from various multiplexed diagnostics technologies such as: Medium Density Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing.
TechNavio's report, Global Multiplexed Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Multiplexed Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Affymetrix
• Agilent Technologies
• Biomeurix
• F. Hoffmann-La Roche
• Illumina
• Thermo Fisher Scientific
Other Prominent Vendors
• Abbott Laboratories
• Becton Dickinson
• Bio-Rad Laboratories
• Cepheid
• Hologic
• Luminex
• Qaigen
• Siemens Healthcare
• ZOLL Medical
Market Driver
• Technological Development
• For a full, detailed list, view our report
Market Challenge
• Accurate Diagnostics Testing
• For a full, detailed list, view our report
Market Trend
• Expanding Economies in the APAC Region
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1 Global Multiplexed Diagnostics Market by Application
08. Market Segmentation by Technology
08.1 Global Medium Density Multiplexed Assays Market
08.1.1 Market Size and Forecast
08.2 Global Low Density Multiplexed Assays Market
08.2.1 Market Size and Forecast
08.3 Global High Density Multiplexed Assays Market
08.3.1 Market Size and Forecast
08.4 Global Very High Density Multiplexed Assays Market
08.4.1 Market Size and Forecast
08.5 Global Next- Generation Sequencing Market
08.5.1 Market Size and Forecast
09. Geographical Segmentation
09.1 Multiplexed Diagnostics Market in the Americas
09.1.1 Market Size and Forecast
09.2 Multiplexed Diagnostics Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 Multiplexed Diagnostics Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
17.4 Affymetrix
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Business Segmentation by Revenue 2013
17.4.5 Business Segmentation by Revenue 2012 and 2013
17.4.6 Sales by Geography
17.4.7 Business Strategy
17.4.8 Key Information
17.4.9 SWOT Analysis
17.5 Agilent Technologies
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation by Revenue 2013
17.5.4 Business Segmentation by Revenue 2012 and 2013
17.5.5 Geographical Segmentation by Revenue 2013
17.5.6 Business Strategy
17.5.7 Recent Developments
17.5.8 SWOT Analysis
17.6 bioMeriux
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Segmentation by Revenue 2013
17.6.4 Geographical Segmentation by Revenue 2013
17.6.5 Business Strategy
17.6.6 Recent Developments
17.6.7 SWOT Analysis
17.7 Illumina
17.7.1 Key Facts
17.7.2 Business Overview
17.7.3 Business Segmentation
17.7.4 Sales Segmentation
17.7.5 Business Strategy
17.7.6 Key Information
17.7.7 SWOT Analysis
17.8 F. Hoffmann-La Roche
17.8.1 Key Facts
17.8.2 Business Overview
17.8.3 Business Segmentation
17.8.4 Sales Segmentation
17.8.5 Business Strategy
17.8.6 Key Information
17.8.7 SWOT Analysis
17.9 Thermo Fisher Scientific
17.9.1 Key Facts
17.9.2 Business Overview
17.9.3 Business Segmentation
17.9.4 Product Segmentation by Revenue
17.9.5 Sales Segmentation
17.9.6 Business Strategy
17.9.7 Key Information
17.9.8 SWOT Analysis
18. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Multiplexed Diagnostics Market 2013-2018 (US$ million)
Exhibit 3: Medium Density Multiplexed Assays Market by Technology Segmentation
Exhibit 4: Low Density Multiplexed Assays Market by Technology Segmentation
Exhibit 5: High Density Multiplexed Assays Market by Technology Segmentation
Exhibit 6: Very High Density Multiplexed Assays Market by Technology Segmentation
Exhibit 7: Global Multiplexed Diagnostics Market Segmentation by Technology 2013
Exhibit 8: Global Medium Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 9: Global Low Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 10: Global High Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 11: Global Very High Density Multiplexed Assays Market 2013-2018 (US$ million)
Exhibit 12: Global Next- Generation Sequencing Market 2013-2018 (US$ million)
Exhibit 13: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018
Exhibit 14: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018 (US$ million)
Exhibit 15: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013
Exhibit 16: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018
Exhibit 17: Multiplexed Diagnostics Market in the Americas 2013-2018 (US$ million)
Exhibit 18: Multiplexed Diagnostics Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 19: Multiplexed Diagnostics Market in the APAC Region 2013-2018 (US$ million)
Exhibit 20: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018 (US$ million)
Exhibit 21: Affymetrix: Business Segmentation 2013
Exhibit 22: Affymetrix: Business Segmentation by Revenue 2013
Exhibit 23: Affymetrix: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 24: Affymetrix: Sales by Geography 2013
Exhibit 25: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 26: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Agilent Technologies: Geographical Segmentation by Revenue 2013
Exhibit 28: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 29: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 30: Illumina: Business Segmentation 2013
Exhibit 31: Illumina: Sales by Geography 2013
Exhibit 32: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 33: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013 and 2012
Exhibit 34: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 35: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 36: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
Exhibit 37: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
Exhibit 38: Thermo Fisher Scientific: Sales by Geography 2013
